FDA Needs Five Centers, Crawford Says; CBER Centennial Is Emotional Affair
This article was originally published in The Gray Sheet
Executive Summary
FDA's five-center structure does not need consolidation beyond the agency's plan to shift biological therapeutic reviews from the Center for Biologics Evaluation & Research to the Center for Drug Evaluation & Research, Acting Commissioner Lester Crawford said